Postthalamic stroke dystonic choreoathetosis responsive to tetrabenazine

Annals of Pharmacotherapy

Volumn 45, Issue 12, 2011, Pages

  Calabrò, Rocco Salvatore ^a   Polimeni, Giovanni ^a   Gervasi, Giuseppe ^a   Bramanti, Placido ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Involuntary movements; Poststroke dystonic choreoathetosis; Tetrabenazine

Indexed keywords

BLOOD CLOTTING FACTOR 5; CLOBAZAM; HALOPERIDOL; OLANZAPINE; PROPRANOLOL; TETRABENAZINE;

ADULT; ANXIETY; ARTICLE; ATAXIA; CAROTID ATHEROSCLEROSIS; CASE REPORT; CHOREOATHETOSIS; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSARTHRIA; DYSTONIC DISORDER; FEMALE; HEMIPARESIS; HUMAN; HYPESTHESIA; LOW DRUG DOSE; MOUTH DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTSTROKE DYSTONIC CHOREOATHETOSIS; PRIORITY JOURNAL; REMISSION; SLEEP DISORDER; STROKE; TARDIVE DYSKINESIA; TONGUE DISEASE; TREATMENT RESPONSE;

ANTIPSYCHOTIC AGENTS; ATHETOSIS; CHOREA; DYSKINESIA, DRUG-INDUCED; DYSTONIA; FEMALE; HUMANS; MIDDLE AGED; STROKE; TETRABENAZINE;

EID: 83155188538     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q366     Document Type: Article

References (12)

1. Ghika-Schmid F, Ghika J, Regli F, Bogousslavsky J. Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry. J Neurol Sci 1997;146:109-16. DOI 10.1016/S0022-510X(96)00290-0
2. Alarcón F, Zijlmans JC, Dueñas G, Cevallos N. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry 2004;75:1568-74. DOI 10.1136/jnnp.2003.011874
3. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009;8:844-56. DOI 10.1016/S1474-4422(09)70183-8
4. Handley A, Medcalf P, Hellier K, Dutta D. Movement disorders after stroke. Age Ageing 2009;38:260-6. DOI 10.1093/ageing/afp020
5. Guy W. ECDEU assessment manual for psychopharmacology, revised ed. Washington, DC: US Department of Health, Education, and Welfare, 1976.
6. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493-507. DOI 10.1002/mds.870090502
7. Fasano A, Bentivoglio AR. Tetrabenazine. Expert Opin Pharmacother 2009;10:2883-96. DOI 10.1517/14656560903386292
8. Kenney C, Jankovic J. Tetrabenazine in the treatment of hyperkinetic movement disorders. Expert Rev Neurother 2006;6:7-17. DOI 10.1586/14737175.6.1.7
9. Jankovic J, Orman J. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology 1988;38:391-4.
10. Sweet RD, Bruun R, Shapiro E, Shapiro AK. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Arch Gen Psychiatry 1974;31:857-61.
11. Jankovic J. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study. Ann Neurol 1982;11:41-7. DOI 10.1002/ana.410110108
12. Astin KJ, Gumpert EW. Tetrabenazine in chorea (letter). Lancet 1974;303:512. DOI 10.1016/S0140-6736(74)92823-2